News | Focused Ultrasound Therapy | April 05, 2016

Eight-minute video profiles patients with various diseases who have been helped by focused ultrasound therapy

April 5, 2016 — The Focused Ultrasound Foundation has produced a video that demonstrates the potential of this new medical technology to revolutionize the treatment of many serious disorders. The short film captures the experience and insights of patients, international researchers, physicians, industry leaders and other supporters of this “breakthrough transformational approach.”

The video features the story of Rick – a patient who felt embarrassed and inadequate because of his tremor. Rick’s outlook was transformed following focused ultrasound treatment at the University of Maryland. The video shows his challenges with conducting simple tasks, chronicles his treatment and captures him drinking steadily from a glass of water just minutes after the procedure — for the first time since childhood. “Focused ultrasound can give someone a new lease on life,” he stated.

Other patients profiled include:

  • Kimberly – a woman with Parkinson’s who is able to get back on her bike after treatment in a clinical trial;
  • Jack – a teenager who is able to play sports again thanks to the non-invasive treatment that eliminated pain caused by a bone tumor; and
  • Elizabeth – who regained her freedom after seeking relief from fibroid symptoms.

“Focused ultrasound treatment has given me back my life - it is a miracle,” said Parkinson’s patient Kimberly.

The 8-minute video also includes 15 experts talking about the potential of focused ultrasound from institutions like Stanford, the University of Virginia, Children’s National Medical Center and Sapienza University of Rome. Animation is used to demonstrate how beams of sound that harmlessly penetrate healthy tissue can be focused to treat a target deep in the body without incisions or other risks of traditional surgery. The therapy has the potential to transform treatment for a range of conditions, including Parkinson’s, Alzheimer’s, depression, pancreatic cancer, prostate cancer, hypertension and brain tumors.

Former National Cancer Institute (NCI) Director and Commissioner of the U.S. Food and Drug Administration (FDA) Andrew von Eschenbach, M.D., urges viewers to take action to support the technology. He closes the video with the statement, “Nothing happens in society unless people want it to. So when people stand up and say ‘we want this,’ then we will do it.”

For more information: www.fusfoundation.org


Related Content

News | Radiopharmaceuticals and Tracers

Jan. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has launched a national program creating Authorized ...

Time January 30, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Radiology Imaging

Jan. 21, 2026 — Cathpax, a spin-off of the Lemer Pax group that designs, develops and commercializes team-wide, full ...

Time January 22, 2026
arrow
News | Radiation Therapy

Jan. 16, 2026 — Elekta has announced that its Elekta Evo* CT-Linac has received 510(k) clearance from the U.S. Food and ...

Time January 16, 2026
arrow
News | Radiation Oncology

Jan. 8, 2026 — RefleXion Medical, an external-beam theranostic oncology company, has announced the U.S. Food and Drug ...

Time January 13, 2026
arrow
News | Radiopharmaceuticals and Tracers

Dec. 11, 2025 — Telix Pharmaceuticals Ltd. has announced a strategic clinical collaboration with Varian, a Siemens ...

Time December 11, 2025
arrow
News | Ultrasound Imaging

Nov 20, 2025 - EDAP TMS SA has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance ...

Time November 21, 2025
arrow
News | Prostate Cancer

Nov. 10, 2025 — Researchers at Wayne State University and the Barbara Ann Karmanos Cancer Institute have developed a ...

Time November 11, 2025
arrow
News | Women's Health

Nov. 3, 2025 — —A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 ...

Time November 04, 2025
arrow
Feature | Kyle Hardner

Radiotherapy contributes to about 40% of all cancer cures but still lags behind systemic therapy in funding and ...

Time October 21, 2025
arrow
Subscribe Now